Who to contact at NGM Biopharmaceuticals about jobs

Jobs Jetty helps you send them a short, personal note from your own resume.

Raised Series A ($122M), Jul 2024

About NGM Biopharmaceuticals

NGM Biopharmaceuticals develops medicines based on human biology. Its lead candidate NGM120 is in Phase 2 trials for hyperemesis gravidarum and cancer cachexia.

Research · 76 people · South San Francisco, United States

Website · LinkedIn page

Join to see who to write to, then send them a note in your own words.

Join Jobs Jetty
AboutQuestionsHiring benchmarksJust fundedWho's hiringPay rangesMy storyBlogHow we verifyPrivacySign inTermsJobs Jetty, a closed community of job seekers helping each other.